Paratek Pharmaceuticals, Inc. Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Paratek Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2023 was 34.5 %, a 47.6% decline year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Return On Equity for 2022 was 40.6 %, a 22.6% decline from 2021.
  • Paratek Pharmaceuticals, Inc. annual Return On Equity for 2021 was 52.4 %, a 59.2% decline from 2020.
  • Paratek Pharmaceuticals, Inc. annual Return On Equity for 2020 was 128 %, a 80.6% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 40.6 -11.8 -22.6% Jan 1, 2022 Dec 31, 2022
2021 52.4 -76 -59.2% Jan 1, 2021 Dec 31, 2021
2020 128 -533 -80.6% Jan 1, 2020 Dec 31, 2020
2019 661 +810 Jan 1, 2019 Dec 31, 2019
2018 -149 -55.5 -59.2% Jan 1, 2018 Dec 31, 2018
2017 -93.6 +39 +29.4% Jan 1, 2017 Dec 31, 2017
2016 -133 -69.3 -109% Jan 1, 2016 Dec 31, 2016
2015 -63.4 -33.7 -114% Jan 1, 2015 Dec 31, 2015
2014 -29.6 -15.1 -103% Jan 1, 2014 Dec 31, 2014
2013 -14.6 +18.5 +56% Jan 1, 2013 Dec 31, 2013
2012 -33.1 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.